Bottom line
VHT vs IHE: the short answer
VHT (Vanguard Health Care Index Fund) and IHE (iShares U.S. Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 41% by weight.
But VHT is far broader, holding 407 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
VHT is cheaper at 0.09% vs 0.37% — a difference of $28 a year per $10,000 invested.
Over five years, IHE returned +9.1% a year vs +7.2% for VHT (reporting dates differ).
Updated Nov 19, 2026
VHT vs IHE side by side
| VHT | IHE | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Vanguard | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.37% |
| Annual cost per $10k | $9 | $37 |
| 10-yr cost on $10k (prospectus) | $115 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.7% | +31.7% |
| 5-yr return (annualized) | +7.2% | +9.1% |
| 10-yr return (annualized) | +8.8% | +6.2% |
| Best quarter | +16.5% | +17.6% |
| Worst quarter | −13.1% | −16.0% |
| Net assets (fund) | $19.0B | $1.1B |
| Number of holdings | 407 | 59 |
| Portfolio turnover | 4% | 29% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHT | IHE | Difference |
|---|---|---|---|
| 2024 | +2.7% | +8.1% | −5.4% |
| 2023 | +2.5% | +1.0% | +1.5% |
| 2022 | −5.5% | −4.8% | −0.7% |
| 2021 | +20.5% | +12.8% | +7.7% |
| 2020 | +18.2% | +13.8% | +4.4% |
| 2019 | +22.0% | +15.5% | +6.5% |
| 2018 | +5.6% | −7.7% | +13.2% |
| 2017 | +23.3% | +10.7% | +12.7% |
| 2016 | −3.3% | −11.7% | +8.4% |
| 2015 | +7.2% | +8.8% | −1.6% |
Source: Fund prospectus bar charts
Holdings overlap
5 of VHT's top 25 holdings also appear in IHE's top 25.
| Holding | VHT | IHE |
|---|---|---|
| Eli Lilly & Co | 14.04% | 22.25% |
| Johnson & Johnson | 8.47% | 22.44% |
| Merck & Co Inc | 4.66% | 4.55% |
| Pfizer Inc | 2.35% | 3.96% |
| Bristol-Myers Squibb Co | 1.84% | 4.37% |
Source: SEC Form N-PORT
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
IHE top 10
- Johnson & Johnson — 22.44%
- Eli Lilly And Company — 22.25%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Merck & Co., Inc. — 4.55%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
FAQ
What is the difference between VHT and IHE?
Which is cheaper, VHT or IHE?
Should I own both VHT and IHE?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.